SG/PUT/NOVO-NORDISK B/800/0.1/20.12.24 | Real-time Boerse Frankfurt Warrants 19:03:11 03/07/2024 BST | ||
| 0.43 EUR | +19.44% |
|
| Current month | +2.86% | ||
| 1 month | -35.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 03/07/24 | 0.43 | +19.44% |
| 02/07/24 | 0.36 | +16.13% |
| 01/07/24 | 0.31 | -11.43% |
| 28/06/24 | 0.35 | +2.94% |
| 27/06/24 | 0.34 | +3.03% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 07:03 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Société Générale
|
| WKN | SU6PNT |
| ISIN | DE000SU6PNT1 |
| Date issued | 08/01/2024 |
| Strike | 800 kr |
| Maturity | 20/12/2024 (170 Days) |
| Parity | 10 : 1 |
| Emission price | 1.97 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.98 € |
|---|---|
| Lowest since issue | 0.27 € |
| Spread | 0.02 € |
| Spread % | 4.55% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5
DKK
Average target price
952.2
DKK
Spread / Average Target
-4.16%
- Stock Market
- Warrants
- Warrant
